Epileptic Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 45.9% | 0.708 | Q2 | 73.3% |
| 2024 | 2.7 | Q2 | 55.4% | 0.713 | Q2 | 74.1% |
| 2023 | 1.9 | Q3 | 46.5% | 0.749 | Q2 | 77.7% |
| 2022 | 2.3 | Q3 | 46.9% | 0.779 | Q2 | 79.8% |
| 2021 | 2.3 | Q4 | 56.3% | 0.693 | Q2 | 77.2% |
| 2020 | — | — | 0.673 | Q2 | 75.1% | |
| 2019 | — | — | 0.676 | Q2 | 76.0% | |
| 2018 | — | — | 0.823 | Q2 | 79.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1294-9361
ISSN
1950-6945
country
UScoverage
1999-2026